A specific amyloid-β protein assembly in the brain impairs memory

Nature

Volumn 440, Issue 7082, 2006, Pages 352-357

  Lesné, Sylvain ^a   Ming, Teng Koh ^b   Kotilinek, Linda ^a   Kayed, Rakez ^d   Glabe, Charles G ^d   Yang, Austin ^e   Gallagher, Michela ^b   Ashe, Karen H ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BRAIN; DISEASES; NEUROLOGY; PATHOLOGY;

AMYLOID-Β PRECURSOR PROTEIN (APP); NEURODEGENERATION; NEUROPATHOLOGY;

PROTEINS;

AMYLOID BETA PROTEIN;

BRAIN; PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; MEMORY DISORDER; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; HUMANS; MAZE LEARNING; MEMORY; MICE; MOLECULAR WEIGHT; PROTEIN STRUCTURE, QUATERNARY; RATS; SENILE PLAQUES; SOLUBILITY; TIME FACTORS;

ANIMALIA;

EID: 33645038471     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature04533     Document Type: Article

References (28)

1. Craik, F. I. in Handbook of the Psychology of Aging (eds Birren, J. E. & Schall, K.) 384-420 (Van Nostrand-Reinhold, New York, 1977).
2. Morrison, J. H. & Hof, P. R. Life and death of neurons in the aging brain. Science 278, 412-419 (1997).
3. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
4. Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K. & Hyman, B. T. APPSW transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965-973 (1997).
5. Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372-381 (2001).
6. Westerman, M. A. et al. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858-1867 (2002).
7. Kawas, C. H. et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 60, 1089-1093 (2003).
8. Small, G. W. et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 6037-6042 (2000).
9. Bookheimer, S. Y. et al. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456 (2000).
10. Albert, M. S. Memory decline: the boundary between aging and age-related disease. Ann. Neurol. 51, 282-284 (2002).
11. SW transgenic mice. Neurobiol. Aging 20, 581-589 (1999).
12. Janus, C. et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982 (2000).
13. Chen, G. et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979 (2000).
14. Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228-3233 (1999).
15. Klein, W. L., Krafft, G. A. & Finch, C. E. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224 (2001).
16. Ashe, K. H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8, 301-308 (2001).
17. Gordon, J. A. & Warren, J. R. Denaturation of globular proteins. I. The interaction of urea and thiourea with bovine plasma albumin. J. Biol. Chem. 243, 5663-5669 (1968).
18. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003).
19. Stern, E. A. et al. Cortical synaptic integration in vivo is disrupted by amyloid-β plaques. J. Neurosci. 24, 4535-4540 (2004).
20. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L. & Laferla, F. M. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688 (2005).
21. Orr, H. T. Neurodegenerative disease: neuron protection agency. Nature 431, 747-748 (2004).
22. SantaCruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481 (2005).
23. Duff, K. & Planel, E. Untangling memory deficits. Nature Med. 11, 826-827 (2005).
24. Gallagher, M., Burwell, R. & Burchinal, M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav. Neurosci. 107, 618-626 (1993).
25. Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
26. Haass, C., Koo, E. H., Mellon, A., Hung, A. Y. & Selkoe, D. J. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503 (1992).
27. Barelli, H. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695-707 (1997).
28. Sergeant, N. et al. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheirner's disease. J. Neurochem. 81, 663-672 (2002).